会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • HAIR COMPOSITION
    • 头发组成
    • WO2016102177A1
    • 2016-06-30
    • PCT/EP2015/078709
    • 2015-12-04
    • UNILEVER PLCUNILEVER N.V.CONOPCO, INC., D/B/A UNILEVER
    • BHOGAL, Ranjit, KaurJENKINS, GailSAWICKA, MagdalenaWAINWRIGHT, Linda, Jane
    • A61K8/49A61K36/88A61K8/63A61Q17/00A61K8/97A61K31/56A61K31/575A61K36/04A61K36/15A61K36/185A61K36/324A61K36/328A61K36/68A61K36/73A61P17/14
    • A61K8/63A61K8/42A61K8/46A61K8/4973A61K8/498A61K8/97A61K31/56A61K31/575A61K36/04A61K36/15A61K36/185A61K36/324A61K36/328A61K36/68A61K36/73A61K36/88A61K2800/592A61K2800/70A61Q7/00A61Q17/00A61K2300/00
    • Disclosed is an oral or topical composition comprising a nuclear factor erythroid-2 related factor 2 agonist and a liver X receptor agonist, wherein the amounts of each of the nuclear factor erythroid-2 related factor 2 agonist and the liver X receptor agonist produce a synergistic benefit of hair fibre growth, wherein the oral or topical composition comprises ≤ 9, preferably ≤ 8 % w/w β-sitosterol, wherein when the oral or topical composition comprises a catechin, the oral or topical composition comprises 0.001 to 90, preferably 0.005 to 70, most preferably 0.01 to 50 % w/w catechins, wherein the oral or topical composition excludes pregnenolone, 4, 5-dihydrofuranodiene-6-one, epoxy santamarin, hydroquinone, longistyline, monacolin K, protoanemonin, N-(2,2,2-trifluoro-ethyl)-N-[4-(2,2,2-tri-fluoro-1-hydroxy-1-trifluoromethyl-ethyl)-phenyl]-benzenesulfonamide, dihydronepetalactone, iridomyrmecin, and dihydroactinidiolide, wherein when the oral or topical composition comprises guggelsterone and epigallocatechin gallate, the oral or topical composition excludes a guggelsterone to epigallocatechin gallate weight ratio of 1 to 28, and wherein when the oral or topical composition comprises sodium dilauramide glutamide lysine, the oral or topical composition excludes 0.3 % w/w sodium dilauramide glutamide lysine.
    • 公开了包含核因子红细胞-2相关因子2激动剂和肝X受体激动剂的口服或局部组合物,其中每个核因子红系2相关因子2激动剂和肝X受体激动剂的量产生协同作用 毛发纤维生长的益处,其中口服或局部组合物包含≤9,优选≤8%w / wβ-谷甾醇,其中当口服或局部组合物包含儿茶素时,口服或局部组合物包含0.001至90,优选0.005 其中口服或局部组合物不包括孕烯醇酮,4,5-二氢呋喃二酮-6-酮,环氧硫胺素,氢醌,长丝氨酸,莫纳可林K,原胰岛素,N-(2, 2,2-二氟乙基)-N- [4-(2,2,2-三氟-1-羟基-1-三氟甲基 - 乙基) - 苯基] - 苯磺酰胺,二氢荆芥内酯,伊立替康和二氢肉豆蔻酸,其中当 口服或局部组合物包括gugg 槲皮素和表没食子儿茶素没食子酸酯,口服或局部组合物不包括凝胶剂至表没食子儿茶素没食子酸酯的重量比为1至28,并且其中当口服或局部组合物包含二月桂酰胺谷氨酰胺赖氨酸钠时,口服或局部组合物不包括0.3%w / w的二月桂酰胺钠 谷氨酰胺赖氨酸。